First Time Loading...

Landos Biopharma Inc
NASDAQ:LABP

Watchlist Manager
Landos Biopharma Inc Logo
Landos Biopharma Inc
NASDAQ:LABP
Watchlist
Price: 22.45 USD 1.1% Market Closed
Updated: May 15, 2024
Section:
 

Wall Street
Price Targets

LABP Price Targets Summary
Landos Biopharma Inc

Wall Street analysts forecast LABP stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LABP is 12.96 USD with a low forecast of 5.05 USD and a high forecast of 21.44 USD.

LABP Lowest Forecast
Wall Street Target
5.05 USD
78% Downside
LABP Average Forecast
Wall Street Target
12.96 USD
42% Downside
LABP Highest Forecast
Wall Street Target
21.44 USD
4% Downside
Lowest
Price Target
5.05 USD
78% Downside
Average
Price Target
12.96 USD
42% Downside
Highest
Price Target
21.44 USD
4% Downside
Landos Biopharma Inc Competitors:
Price Targets
002422
Sichuan Kelun Pharmaceutical Co Ltd
19% Upside
DERM
Journey Medical Corp
121% Upside
I
007570
Ilyang Pharmaceutical Co Ltd
217% Upside
002020
Zhejiang Jingxin Pharmaceutical Co Ltd
9% Upside
002422
Sichuan Kelun Pharmaceutical Co Ltd
19% Upside
DERM
Journey Medical Corp
121% Upside
I
007570
Ilyang Pharmaceutical Co Ltd
217% Upside
002020
Zhejiang Jingxin Pharmaceutical Co Ltd
9% Upside
WEED
Canopy Growth Corp
38% Downside
SUPN
Supernus Pharmaceuticals Inc
43% Upside
300026
Tianjin Chase Sun Pharmaceutical Co Ltd
459% Upside
C
1701
China Chemical & Pharmaceutical Co Ltd
35% Upside

Revenue
Forecast

Revenue Estimate
Landos Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Landos Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Landos Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
29%
Average Beat
What are analyst estimates?

See Also

Summary
LABP intrinsic value, competitors valuation, and company profile.
DCF Valuation
LABP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LABP stock valuation using valuation multiples.
Wall Street Estimates
LABP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LABP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LABP's stock price target?
Price Target
12.96 USD

According to Wall Street analysts, the average 1-year price target for LABP is 12.96 USD with a low forecast of 5.05 USD and a high forecast of 21.44 USD.

ALPHA SPREAD
Join more than 137,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.